Arcutis Other Non Cash Items vs Depreciation Analysis

ARQT Stock  USD 12.69  0.44  3.59%   
Arcutis Biotherapeutics financial indicator trend analysis is way more than just evaluating Arcutis Biotherapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arcutis Biotherapeutics is a good investment. Please check the relationship between Arcutis Biotherapeutics Other Non Cash Items and its Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcutis Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.

Other Non Cash Items vs Depreciation

Other Non Cash Items vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Arcutis Biotherapeutics Other Non Cash Items account and Depreciation. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Arcutis Biotherapeutics' Other Non Cash Items and Depreciation is 0.16. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Depreciation in the same time period over historical financial statements of Arcutis Biotherapeutics, assuming nothing else is changed. The correlation between historical values of Arcutis Biotherapeutics' Other Non Cash Items and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Arcutis Biotherapeutics are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Other Non Cash Items i.e., Arcutis Biotherapeutics' Other Non Cash Items and Depreciation go up and down completely randomly.

Correlation Coefficient

0.16
Relationship DirectionPositive 
Relationship StrengthInsignificant

Other Non Cash Items

Depreciation

Depreciation indicates how much of Arcutis Biotherapeutics value has been used up. For tax purposes Arcutis Biotherapeutics can deduct the cost of the tangible assets it purchases as business expenses. However, Arcutis Biotherapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Arcutis Biotherapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arcutis Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arcutis Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.At this time, Arcutis Biotherapeutics' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 3.3 M in 2024, despite the fact that Enterprise Value Multiple is likely to grow to (1.43).

Arcutis Biotherapeutics fundamental ratios Correlations

0.960.960.870.920.53-0.820.940.880.861.00.910.820.710.930.870.880.780.971.01.0-0.930.670.820.950.94
0.961.00.780.90.64-0.890.990.860.90.940.970.770.750.950.910.920.820.940.960.95-0.950.560.910.90.97
0.961.00.780.90.64-0.90.990.860.90.930.960.780.750.950.910.930.820.940.950.94-0.950.550.910.90.97
0.870.780.780.950.28-0.570.770.70.540.90.640.590.280.80.680.740.380.930.880.88-0.840.880.540.950.84
0.920.90.90.950.4-0.710.90.780.670.910.790.650.410.880.790.830.520.960.920.91-0.910.830.680.970.94
0.530.640.640.280.4-0.840.610.280.710.490.620.330.610.690.650.780.640.570.520.51-0.7-0.160.870.450.6
-0.82-0.89-0.9-0.57-0.71-0.84-0.89-0.74-0.9-0.78-0.9-0.74-0.78-0.94-0.95-0.97-0.83-0.79-0.82-0.80.92-0.27-0.93-0.77-0.9
0.940.990.990.770.90.61-0.890.860.910.910.950.80.720.940.90.920.80.920.940.93-0.930.570.880.90.98
0.880.860.860.70.780.28-0.740.860.80.880.890.940.740.830.870.750.790.760.880.88-0.790.660.650.830.85
0.860.90.90.540.670.71-0.90.910.80.830.920.860.910.850.840.860.950.780.860.85-0.830.270.920.740.85
1.00.940.930.90.910.49-0.780.910.880.830.890.820.680.910.850.860.750.961.01.0-0.920.70.780.950.92
0.910.970.960.640.790.62-0.90.950.890.920.890.810.860.90.920.870.910.840.910.9-0.880.440.90.810.91
0.820.770.780.590.650.33-0.740.80.940.860.820.810.780.780.810.720.810.670.820.82-0.730.50.630.760.77
0.710.750.750.280.410.61-0.780.720.740.910.680.860.780.660.720.660.990.560.70.7-0.620.040.830.490.63
0.930.950.950.80.880.69-0.940.940.830.850.910.90.780.660.970.990.740.920.930.92-0.990.560.860.930.97
0.870.910.910.680.790.65-0.950.90.870.840.850.920.810.720.970.950.780.820.870.86-0.940.480.830.860.93
0.880.920.930.740.830.78-0.970.920.750.860.860.870.720.660.990.950.730.890.880.87-0.980.450.890.880.95
0.780.820.820.380.520.64-0.830.80.790.950.750.910.810.990.740.780.730.650.780.77-0.70.130.880.590.72
0.970.940.940.930.960.57-0.790.920.760.780.960.840.670.560.920.820.890.650.970.96-0.950.690.810.960.94
1.00.960.950.880.920.52-0.820.940.880.861.00.910.820.70.930.870.880.780.971.0-0.930.670.820.950.94
1.00.950.940.880.910.51-0.80.930.880.851.00.90.820.70.920.860.870.770.961.0-0.920.680.80.950.93
-0.93-0.95-0.95-0.84-0.91-0.70.92-0.93-0.79-0.83-0.92-0.88-0.73-0.62-0.99-0.94-0.98-0.7-0.95-0.93-0.92-0.57-0.86-0.94-0.97
0.670.560.550.880.83-0.16-0.270.570.660.270.70.440.50.040.560.480.450.130.690.670.68-0.570.180.80.64
0.820.910.910.540.680.87-0.930.880.650.920.780.90.630.830.860.830.890.880.810.820.8-0.860.180.70.83
0.950.90.90.950.970.45-0.770.90.830.740.950.810.760.490.930.860.880.590.960.950.95-0.940.80.70.95
0.940.970.970.840.940.6-0.90.980.850.850.920.910.770.630.970.930.950.720.940.940.93-0.970.640.830.95
Click cells to compare fundamentals

Arcutis Biotherapeutics Account Relationship Matchups

Arcutis Biotherapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets107.0M298.3M408.2M449.3M341.4M260.7M
Other Current Liab3.7M15.5M25.1M27.7M33.2M16.7M
Total Current Liabilities5.2M22.6M33.3M37.8M46.7M23.4M
Total Stockholder Equity(65.0M)270.6M297.7M209.6M88.7M121.4M
Net Tangible Assets(65.0M)270.6M297.7M202.4M232.8M124.1M
Net Debt(63.0M)(60.1M)(18.9M)148.9M117.5M123.4M
Retained Earnings(66.3M)(202.0M)(408.3M)(719.8M)(981.9M)(932.8M)
Accounts Payable1.4M7.1M7.4M8.8M12.0M6.1M
Cash63.3M65.1M96.4M53.6M88.4M64.4M
Non Current Assets Total538K5.4M5.4M11.9M10.9M11.5M
Cash And Short Term Investments101.3M284.4M387.1M409.6M271.9M237.1M
Common Stock Shares Outstanding38.1M35.7M49.4M55.0M69.3M44.6M
Short Term Investments37.9M219.4M290.6M355.9M183.5M172.7M
Liabilities And Stockholders Equity107.0M298.3M408.2M449.3M341.4M260.7M
Non Current Liabilities Total166.8M5.0M77.1M201.9M206.0M115.9M
Capital Surpluse289K1.2M472.6M706.2M812.2M852.8M
Other Current Assets5.2M7.9M15.7M11.8M19.6M20.6M
Other Stockholder Equity(165.2M)472.6M706.2M930.4M1.1B1.1B
Total Liab172.0M27.6M110.5M239.7M252.7M139.3M
Net Invested Capital(65.0M)270.6M370.0M407.4M290.5M195.6M
Total Current Assets106.5M292.8M402.8M437.4M330.4M255.3M
Net Working Capital101.2M270.2M369.4M399.6M283.8M231.9M
Non Current Liabilities Other184K5.0M4.8M849K976.4K927.5K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.